Does complete-staging lymphadenectomy improve survival outcomes in stage I endometrioid epithelial ovarian carcinoma? A multi-institutional retrospective study with propensity score-weighted analysis

被引:4
作者
Yoshihara, Masato [1 ]
Tamauchi, Satoshi [1 ]
Iyoshi, Shohei [1 ,2 ]
Kitami, Kazuhisa [1 ]
Uno, Kaname [1 ,3 ]
Tano, Sho [1 ]
Matsui, Shigeyuki [4 ]
Kajiyama, Hiroaki [1 ]
机构
[1] Nagoya Univ, Dept Obstet & Gynecol, Grad Sch Med, Nagoya, Aichi, Japan
[2] Univ Freiburgs, Fac Med, Albertstr, Freiburg, Germany
[3] Lund Univ, Fac Med, Lund, Sweden
[4] Nagoya Univ, Dept Biostat, Grad Sch Med, Nagoya, Aichi, Japan
关键词
carcinoma; endometrioid; epithelial ovarian carcinoma; lymph node excision; prognosis;
D O I
10.1093/jjco/hyaa206
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: We investigated the prognostic impact of complete-staging lymphadenectomy on patients with clinically apparent Stage I endometrioid epithelial ovarian carcinoma. Methods: We conducted a regional multi-institutional retrospective study between 1986 and 2018. Amongst 4897 patients with malignant ovarian tumours diagnosed under central pathological review, 259 women with Stage I endometrioid epithelial ovarian carcinoma were eligible. We evaluated differences in survival of patients with both pelvic and para-aortic lymphadenectomy (Group A) and those with only pelvic lymphadenectomy and/or clinical lymph node evaluation (Group B). To analyse the therapeutic effects, the baseline imbalance between patients with both pelvic and para-aortic lymphadenectomy and others was adjusted with an inverse probability of treatment weighting using propensity score involving independent clinical variables. Results: In total, 145 patients (56.0%) received both pelvic and para-aortic lymphadenectomy. With propensity score-based adjustment, estimated survival was better in Group A compared with that in Group B but not significant. Pelvic and para-aortic lymphadenectomy also led to no significant improvement of overall survival in most of the subgroups. However, point estimations of the hazard ratio for lymphadenectomy in patients with an age of 45 or younger (hazard ratio, 0.304; 95% confidence interval, 0.094-0.982), a Grade 1-2 (hazard ratio, 0.441; 95% confidence interval, 0.204-0.954) and T1c2-3 tumour (hazard ratio, 0.449; 95% confidence interval, 0.164-1.231) were better compared with those with the opposite characteristics. Conclusions: Complete-staging lymphadenectomywas not a significant prognostic factor in patients with Stage I endometrioid epithelial ovarian carcinoma, where we still need to explore appropriate candidate for the procedure.
引用
收藏
页码:387 / 392
页数:6
相关论文
共 22 条
  • [1] Bouchard-Fortier G, 2017, J OBSTET GYNAECOL CA, V39, P34, DOI 10.1016/j.jogc.2016.10.006
  • [2] Association of lymphadenectomy and survival in stage I ovarian cancer patients
    Chan, John K.
    Munro, Elizabeth G.
    Cheung, Michael K.
    Husain, Amreen
    Teng, Nelson N.
    Berek, Jonathan S.
    Osann, Kathryn
    [J]. OBSTETRICS AND GYNECOLOGY, 2007, 109 (01) : 12 - 19
  • [3] Pathology and classification of ovarian tumors
    Chen, VW
    Ruiz, B
    Killeen, JL
    Coté, TR
    Wu, XC
    Correa, CN
    [J]. CANCER, 2003, 97 (10) : 2631 - +
  • [4] The impact of lymph node dissection and adjuvant chemotherapy on survival: A nationwide cohort study of patients with clinical early-stage ovarian cancer
    Kleppe, Marjolein
    van der Aa, Maaike A.
    Van Gorp, Toon
    Slangen, Brigitte F. M.
    Kruitwagen, Roy F. P. M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 66 : 83 - 90
  • [5] Early-Stage Endometrioid Ovarian Carcinoma Population-Based Outcomes in British Columbia
    Kumar, Aalok
    Le, Nhu
    Tinker, Anna V.
    Santos, Jennifer L.
    Parsons, Christina
    Hoskins, Paul J.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (08) : 1401 - 1405
  • [6] Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis
    Maggioni, A.
    Panici, P. Benedetti
    Dell'Anna, T.
    Landoni, F.
    Lissoni, A.
    Pellegrino, A.
    Rossi, R. S.
    Chiari, S.
    Campagnutta, E.
    Greggi, S.
    Angioli, R.
    Manci, N.
    Calcagno, M.
    Scambia, G.
    Fossati, R.
    Floriani, I.
    Torri, V.
    Grassi, R.
    Mangioni, C.
    [J]. BRITISH JOURNAL OF CANCER, 2006, 95 (06) : 699 - 704
  • [7] Lymph node involvement in epithelial ovarian cancer:: Analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications
    Morice, P
    Joulie, F
    Camatte, S
    Atallah, D
    Rouzier, R
    Pautier, P
    Pomel, C
    Lhommé, C
    Duvillard, P
    Castaigne, D
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2003, 197 (02) : 198 - 205
  • [8] Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: Annual patients report for 2015 and annual treatment report for 2010
    Nagase, Satoru
    Ohta, Tsuyoshi
    Takahashi, Fumiaki
    Enomoto, Takayuki
    Yaegashi, Nobuo
    Ino, Kazuhiro
    Ushijima, Kimio
    Shozu, Makio
    Tashiro, Hironori
    Mandai, Masaki
    Mikami, Mikio
    Miyamoto, Shingo
    Morishige, Kenichiro
    Yoshida, Yoshio
    Yamagami, Wataru
    Yoshino, Kiyoshi
    Tokunaga, Hideki
    Saito, Toshiaki
    Katabuchi, Hidetaka
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2019, 45 (02) : 289 - 298
  • [9] Does tumor grade influence the rate of lymph node metastasis in apparent early stage ovarian cancer?
    Nasioudis, Dimitrios
    Mastroyannis, Spyridon A.
    Ko, Emily M.
    Latif, Nawar A.
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2018, 298 (01) : 179 - 182
  • [10] Prognostic significance of lymphadenectomy and prevalence of lymph node metastasis in clinically-apparent stage I endometrioid and mucinous ovarian carcinoma
    Nasioudis, Dimitrios
    Chapman-Davis, Eloise
    Witkin, Steven S.
    Holcomb, Kevin
    [J]. GYNECOLOGIC ONCOLOGY, 2017, 144 (02) : 414 - 419